Ribociclib plus letrozole alters the immune subset composition in older (≥70 yrs.) patients with HR+/HER2-metastatic breast cancer

被引：0
|
作者：
Lambrechts, Yentl
Hatse, Sigrid
Kenis, Cindy
Decoster, Lore
de Azambuja, Evandro
Jerusalem, Guy
Neven, Patrick
Dal Lago, Lissandra
Denys, Hannelore
Vuylsteke, Peter
Cornelis, Frank
Punie, Kevin
Floris, Giuseppe
Desmedt, Christine
Laenen, Annouschka
Ponde, Noam
Wildiers, Hans
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P4-01-29
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-01-29
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Real-world study of patients with HR+/ HER2-metastatic breast cancer treated with palbociclib and fulvestrant
    Robert, Nicholas
    Chen, Connie
    Doan, Justin
    Venkatasetty, Divea
    Espirito, Janet L.
    Aguilar, Kathleen M.
    FUTURE ONCOLOGY, 2025, 21 (01) : 83 - 94
  • [32] Ribociclib (Kisqali®) from Novartis shows almost 5 Years of Overall Survival in pre- and perimenopausal Patients with HR+/ HER2-metastatic Breast Cancer
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 (03)
  • [33] Ribociclib plus fulvestrant in postmenopausal women with HR+, HER2-advanced breast cancer (ABC)
    Tolaney, S. M.
    Forero-Torres, A.
    Boni, V.
    Bachelot, T.
    Lu, Y-S
    Maur, M.
    Fasolo, A.
    Motta, M.
    Pan, C.
    Dobson, J.
    Hewes, B.
    Lee, S. Chin
    CANCER RESEARCH, 2017, 77
  • [34] Ribociclib for post-menopausal women with HR+/HER2-advanced or metastatic breast cancer
    Zangardi, Mark L.
    Spring, Laura M.
    Blouin, Gayle C.
    Bardia, Aditya
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (11) : 1169 - 1176
  • [35] Effect of Neoadjuvant Letrozole and Ribociclib on Nodal Pathologic Response in HR+/Her2-Breast Cancer (FELINE Trial)
    Abbassi-Rahbar, Shahrzad
    Khan, Qamar J.
    Fan, Fang
    Gloyeske, Nika C.
    Larson, Kelsey E.
    Amin, Amanda L.
    Balanoff, Christa R.
    Kilgore, Lyndsey J.
    Sharma, Priyanka
    O'Dea, Anne P.
    Nye, Lauren
    O'Regan, Ruth
    Wisinski, Kari B.
    Kalinsky, Kevin
    Trivedi, Meghna
    Bardia, Aditya
    Spring, Laura
    Ma, Cynthia
    Yuan
    Mudaranthakam, Dinesh Pal
    Wagner, Jamie L.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 2) : S247 - S248
  • [36] COST-EFFECTIVENESS OF PALBOCICLIB PLUS LETROZOLE IN THE TREATMENT OF HR+/HER2-ADVANCED OR METASTATIC BREAST CANCER IN ECUADOR
    Cabezas, M.
    Freire, V
    Salcedo, E.
    Albert, A.
    VALUE IN HEALTH, 2018, 21 : S32 - S32
  • [37] Breast cancer specific survival (BCSS) in HR+/HER2-metastatic breast cancer (mBC) from 2010 to 2019
    Brufsky, A. M.
    Kwan, M.
    Sandin, R.
    Karanth, S.
    Cha-Silva, A.
    Makari, D.
    Stergiopoulos, S.
    Goyal, R.
    ANNALS OF ONCOLOGY, 2023, 34 : S351 - S352
  • [38] Cost-Effectiveness of Ribociclib plus Letrozole Versus Palbociclib plus Letrozole and Letrozole Monotherapy in the First-Line Treatment of Postmenopausal Women with HR+/HER2-Advanced or Metastatic Breast Cancer: A US Payer Perspective
    Mistry, Rohit
    May, Jessica R.
    Suri, Gaurav
    Young, Kate
    Brixner, Diana
    Oderda, Gary
    Biskupiak, Joseph
    Tang, Derek
    Bhattacharyya, Subrata
    Mishra, Dinesh
    Bhattacharyya, Devarshi
    Dalal, Anand A.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (06): : 514 - +
  • [39] Identifying drivers of first-line HR+/HER2-metastatic breast cancer treatment choices
    Brufsky, Adam
    Maculaitis, Martine C.
    Kopenhafer, Lewis
    Olsen, Patrick
    Kurosky, Samantha K.
    Arruda, Lillian Shahied
    Heck, Wendy
    Cha-Silva, Ashley S.
    FUTURE ONCOLOGY, 2024, 20 (29) : 2165 - 2177
  • [40] COMPARING EFFICACYAND TOXICITY IN HR+/HER2-METASTATIC BREAST CANCER PATIENTS TREATED WITH RIBOCICLIB OR PALBOCICLIB IN COMBINATION WITH ENDOCRINE THERAPY: RESULTS FROM A SINGLE CENTER IN MEXICO
    Maliachi Diaz, Andrea
    Garcia Padilla, Daniel Alejandro
    Zilli Hernandez, Stefan
    Arce Salinas, Claudia Haydee
    Flores Diaz, Diana Fabiola
    Matus Santos, Juan Antonio
    Espinosa Fernandez, Jose Rodrigo
    Gonzalez Nunez, Carlos Arturo
    Garcilazo Reyes, Alexandra
    Alvarado Miranda, Alberto
    Lara Medina, Fernando Ulises
    Velazquez Martinez, Areli
    Salinas Agramonte, Luis Andre
    Santamaria Galicia, Julieta
    Cabrera Galeana, Paula Anel
    BREAST, 2023, 71 : S50 - S50
12345